Want to see IN:NATHBIOGEN full AI Analyst Report?
Nath Bio-Genes (India) Ltd. (NATHBIOGEN) Ratios
Nath Bio-Genes (India) Ltd. Ratios
IN:NATHBIOGEN's free cash flow for Q1 2027 was $0.00. For the 2027 fiscal year, IN:NATHBIOGEN's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.97 | 1.89 | 2.18 | 2.41 | 2.41 |
| Quick Ratio | 0.83 | 0.96 | 1.30 | 1.45 | 1.27 |
| Cash Ratio | 0.19 | 0.24 | 0.29 | 0.18 | 0.02 |
| Solvency Ratio | 0.11 | 0.11 | 0.16 | 0.17 | -0.32 |
| Operating Cash Flow Ratio | -0.06 | 0.05 | 0.28 | 0.18 | 0.09 |
| Short-Term Operating Cash Flow Coverage | -0.18 | 0.16 | 0.71 | 0.37 | 0.18 |
| Net Current Asset Value | $ 3.62B | $ 3.08B | $ 3.01B | $ 3.01B | $ 2.68B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.13 | 0.12 | 0.13 | 0.13 | 0.13 |
| Debt-to-Equity Ratio | 0.20 | 0.19 | 0.18 | 0.18 | 0.17 |
| Debt-to-Capital Ratio | 0.17 | 0.16 | 0.15 | 0.16 | 0.15 |
| Long-Term Debt-to-Capital Ratio | 0.02 | 0.02 | 0.01 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.61 | 1.59 | 1.44 | 1.38 | 1.37 |
| Debt Service Coverage Ratio | 0.45 | 0.40 | 0.45 | 0.42 | -0.52 |
| Interest Coverage Ratio | 3.03 | 4.39 | 5.41 | 16.97 | 12.93 |
| Debt to Market Cap | 0.54 | 0.41 | 0.32 | 0.39 | 0.23 |
| Interest Debt Per Share | 77.86 | 69.39 | 62.70 | 60.74 | 54.52 |
| Net Debt to EBITDA | 0.94 | 0.67 | 0.61 | 1.37 | -1.79 |
| Profitability Margins | |||||
| Gross Profit Margin | 45.80% | 62.85% | 41.66% | 55.33% | 55.46% |
| EBIT Margin | 13.99% | 12.60% | 20.28% | 15.18% | -18.96% |
| EBITDA Margin | 14.89% | 13.65% | 21.67% | 16.23% | -17.86% |
| Operating Profit Margin | 10.89% | 12.60% | 19.27% | 57.52% | 49.43% |
| Pretax Profit Margin | 10.40% | 10.97% | 16.79% | 12.05% | -22.77% |
| Net Profit Margin | 9.35% | 10.58% | 16.01% | 11.62% | -24.19% |
| Continuous Operations Profit Margin | 9.35% | 10.58% | 16.01% | 11.62% | -24.21% |
| Net Income Per EBT | 89.91% | 96.39% | 95.32% | 96.40% | 106.23% |
| EBT Per EBIT | 95.52% | 87.09% | 87.13% | 20.96% | -46.07% |
| Return on Assets (ROA) | 3.79% | 3.76% | 4.50% | 4.42% | -9.08% |
| Return on Equity (ROE) | 6.12% | 5.99% | 6.50% | 6.11% | -12.42% |
| Return on Capital Employed (ROCE) | 6.90% | 6.96% | 7.72% | 30.07% | 25.13% |
| Return on Invested Capital (ROIC) | 5.29% | 5.67% | 6.29% | 24.64% | 21.58% |
| Return on Tangible Assets | 3.81% | 3.79% | 4.55% | 4.47% | -9.23% |
| Earnings Yield | 16.26% | 13.06% | 11.46% | 13.04% | -16.61% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.21 | 4.10 | 2.62 | 3.10 | 3.25 |
| Payables Turnover | 1.84 | 1.71 | 3.34 | 4.85 | 2.90 |
| Inventory Turnover | 0.54 | 0.40 | 0.63 | 0.65 | 0.56 |
| Fixed Asset Turnover | 1.83 | 1.50 | 0.88 | 1.29 | 1.20 |
| Asset Turnover | 0.41 | 0.36 | 0.28 | 0.38 | 0.38 |
| Working Capital Turnover Ratio | 1.26 | 1.15 | 0.81 | 1.04 | 0.87 |
| Cash Conversion Cycle | 553.30 | 785.09 | 611.74 | 606.35 | 635.03 |
| Days of Sales Outstanding | 70.04 | 88.92 | 139.07 | 117.91 | 112.24 |
| Days of Inventory Outstanding | 681.63 | 910.20 | 582.11 | 563.66 | 648.75 |
| Days of Payables Outstanding | 198.37 | 214.03 | 109.43 | 75.22 | 125.96 |
| Operating Cycle | 751.67 | 999.13 | 721.17 | 681.57 | 760.99 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -11.10 | 9.17 | 39.25 | 20.19 | 8.97 |
| Free Cash Flow Per Share | -12.62 | 5.04 | 25.16 | 18.85 | -2.09 |
| Dividend Paid and CapEx Coverage Ratio | -3.24 | 1.50 | 2.44 | 6.04 | 0.69 |
| Capital Expenditure Coverage Ratio | -7.33 | 2.22 | 2.79 | 15.05 | 0.81 |
| Operating Cash Flow Coverage Ratio | -0.16 | 0.14 | 0.68 | 0.36 | 0.18 |
| Operating Cash Flow to Sales Ratio | -0.05 | 0.05 | 0.30 | 0.13 | 0.06 |
| Free Cash Flow Yield | -9.78% | 3.27% | 13.83% | 13.34% | -0.98% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 6.15 | 7.59 | 8.73 | 7.67 | -6.02 |
| Price-to-Sales (P/S) Ratio | 0.58 | 0.81 | 1.40 | 0.89 | 1.46 |
| Price-to-Book (P/B) Ratio | 0.38 | 0.46 | 0.57 | 0.47 | 0.75 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -10.22 | 30.59 | 7.23 | 7.49 | -102.12 |
| Price-to-Operating Cash Flow Ratio | -11.62 | 16.81 | 4.63 | 7.00 | 23.79 |
| Price-to-Earnings Growth (PEG) Ratio | 1.86 | -2.93 | 0.66 | -0.05 | 0.03 |
| Enterprise Value Multiple | 4.81 | 6.61 | 7.06 | 6.87 | -9.94 |
| Enterprise Value | 3.19B | 3.29B | 3.79B | 3.36B | 4.94B |
| EV to EBITDA | 4.81 | 6.61 | 7.06 | 6.87 | -9.94 |
| EV to Sales | 0.72 | 0.90 | 1.53 | 1.11 | 1.78 |
| EV to Free Cash Flow | -12.72 | 34.06 | 7.92 | 9.37 | -124.48 |
| EV to Operating Cash Flow | -14.46 | 18.72 | 5.08 | 8.75 | 28.99 |
| Tangible Book Value Per Share | 340.11 | 332.47 | 316.31 | 296.12 | 278.86 |
| Shareholders’ Equity Per Share | 342.92 | 336.21 | 320.94 | 301.61 | 285.19 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.10 | 0.05 | 0.05 | 0.03 | -0.06 |
| Revenue Per Share | 224.31 | 190.39 | 130.25 | 158.54 | 146.47 |
| Net Income Per Share | 20.98 | 20.14 | 20.85 | 18.42 | -35.43 |
| Tax Burden | 0.90 | 0.96 | 0.95 | 0.96 | 1.06 |
| Interest Burden | 0.74 | 0.87 | 0.83 | 0.79 | 1.20 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.05 | 0.03 | 0.03 |
| SG&A to Revenue | 0.28 | 0.41 | 0.03 | 0.02 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.53 | 0.46 | 1.79 | 1.06 | -0.27 |
Currency in INR
